A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients

American Journal of Therapeutics

Volumn 4, Issue 2-3, 1997, Pages 85-91

  Hanes, Donna S ^a   Geoffrey Nicholson, P ^a   Raval, Ditina D ^a   Hooper, Frank L ^a   Behrens, Mary T ^a   Weir, Matthew R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

gemfibrozil; hyperlipidemia; lovastatin; organ transplantation

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MEVINOLIN; PREDNISONE; TRIACYLGLYCEROL;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT;

EID: 0030946246     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199702000-00006     Document Type: Article

References (32)

1. Miller LW, Noedel N, Pennington DG, et al.: Treatment of hypercholesterolemia in cardiac transplant recipients with lovastatin (abstract). J Heart Transpl 1989;8:105.
2. Kirkman RL, Strom TB, Weir MR, et al.: Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 1982;34:347.
3. Schweitzer EJ, Matas AJ, Gillingham KJ, et al.: Causes of renal allograft loss. Ann Surg 1991;214:679.
4. Advisory Committee to the Renal Transplant Registry: The 12th report of the human renal transplant registry. JAMA 1975;233:787.
5. Keogh A, Simons L, Spratt P, et al.: Hyperlipidemia after heart transplantation. J Heart Transplant 1988;7:171.
6. Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988;84:985.
7. Cattran DC, Steiner GL, Wilson DR, et al.: Hyperlipidemia after renal transplantation: Natural history and pathophysiology. Ann Intern Med 1979;91:554.
8. Ponticelli C, Barbi GK, Cantaluppi A, et al.: Lipid disorders in renal transplant recipients. Nephron 1978;20:189.
9. Kropp KA, Wolfe C, Jhunjhunwala JS, et al.: Cyclosporine versus azathioprine: review of 200 consecutive cadaver renal transplant recipients. J Urol 1989;142:28.
10. Markell MS, Friedman EA: Cyclosporine, hyperlipidemia after organ transplantation. Am J Med 1989;87:5.
11. Grundy SM: Management of hyperlipidemia of kidney disease. Kidney Int 1990;37:847.
12. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982;248:1465.
13. Castelli WP, et al.: Incidence of coronary heart disease and lipoprotein cholesterol levels; the Framingham Study. JAMA 1986;256:2835.
14. Frick MH, Elo O, Haapa K, et al.: Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987;317: 1237.
15. Lipid Research Clinics Program: The lipid research clinics coronary primary prevention trial results. JAMA 1984;51:351.
16. Kobashigawa JA, Murphy FL, Stevenson LW, et al.: Low-dose lovastatin safely lowers cholesterol after cardiac transplantation. Circulation 1990;82(suppl IV):IV-281.
17. Knight RJ, Vathsala A, Schoenberg L, et al.: Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification. Transplantation 1992; 53:224.
18. Cheung AK, DeVault GA, Gregory MC: A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine. J Am Soc Nephrol 1993;3:1884.
19. Kasiske BL, Tortorice KL, Heim-Dulthoy KL, et al.: Lovastatin treatment of hypercholesterolemia in renal transplant recipients. Transplantation 1990;49:95.
20. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, National Cholesterol Education Program: Summary of the NCEP adult treatment panel II report. JAMA 1993;269:3015.
21. Henninghake DB, Stein EA, Dujovne CA, et al.: The efficacy of intensive dietary therapy alone or in combination with lovastatin in outpatients with hypercholesterolemia. N Eng J Med 1993;328:1213.
22. Corpier CL, Jones PH, Suki WN, et al.: Rhabdomyolysis and renal injury with lovastatin use. JAMA 1988;260:239.
23. Castelaeo AM, Grino JM, Andres E, et al.: HMGCoA reductase inhibitors, lovastatin and simvastatin, in the treatment of hypercholesterolemia after renal transplantation. Transplant Proc 1993;25:1043.
24. Kronbach T, Fischer V, Meyer UA, et al.: Cytochrome metabolism in human liver: identification of a cytochrome P450III gene family as the major cyclosporine metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharm Ther 1988;43:630.
25. Peters JR, Kubo SH, Olivari MT, et al.: Treatment of hyperlipidemia in heart transplant recipients with gemfibrozil ± lovastatin. Am J Cardiol 1993;71:1485.
26. Committee of Principal Investigators, WHO Cooperative Trial: A cooperative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978;40:1069.
27. Kuo PC, Kirshenbaum JM, Gordon J, et al.: Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol 1989;64:631.
28. Bradford RH, Shear CL, Chremos AN, et al.: Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am J Med 1991;91(Suppl 1B):185.
29. Yoshimura N, Oka T, Okamoto M, et al.: The effects of pravastatin on hyperlipidemia in renal transplant recipients. Transplantation 1992;53:94.
30. Traindl O, Reading S, Franz M, et al.: Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL cholesterol and lipoprotein (a). Nephron 1992;62:394.
31. Marais GE, Larsen KK, et al.: Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Ann Intern Med 1990;112:228.
32. Wiklund O, Angelin B, Bergman M, et al.: Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med 1994;96: 300.